Caribou Biosciences appoints Sri Ryali as CFO

Caribou Biosciences (CRBU) appointed Sri Ryali as CFO, effective immediately. Most recently, Ryali served as CFO of Codexis, a publicly traded enzyme engineering company. Previously, he served as CFO of Eiger BioPharmaceuticals, then a publicly traded, commercial-stage company. Previously at Aimmune Therapeutics, Ryali held roles of increasing responsibility, most recently as VP of Finance. Earlier in his career, he worked at Onyx Pharmaceuticals and Amgen in finance-related positions of increasing responsibility.